Company Profiles

driven by the PitchBook Platform

BioVascular

Description

Developer of drugs and devices for the control of platelet mediated cardiovascular diseases. The company conducts human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.

2005

Founded

PRIVATE

Status

1-10

Employees

Series C

Latest Deal Type

$10.9M

Latest Deal Amount

$19M

Total Amount Raised

Description

Developer of drugs and devices for the control of platelet mediated cardiovascular diseases. The company conducts human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.

Website:

www.biovascularinc.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

12230 El Camino Real Suite 100 San Diego, CA 92130United States +1 (858) 455-5000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore BioVascular's full profile, request a free trial.

BioVascular Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

BioVascular Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

BioVascular Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BB BiotechVenture CapitalMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Merck Capital VenturesCorporate Venture CapitalMinority000 0000000 0000
BB Biotech Venture Capital
Domain Associates Venture Capital
Merck Capital Ventures Corporate Venture Capital

BioVascular Executive Team (2)

NameTitleBoard
Seat
Contact
Info
John Parrish Ph.DCo-Founder, President, Chief Executive Officer & Board Member
Christopher Bussineau Ph.DVice President, Pharmaceutical Operations
John Parrish Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Christopher Bussineau Ph.D Vice President, Pharmaceutical Operations

BioVascular Board Members (5)

NameRepresentingRoleSinceContact
Info
Arno Hartmann Ph.DSelfBoard Member000 0000
Brian DoveyDomain AssociatesBoard Member000 0000
John Parrish Ph.DBioVascularCo-Founder, President, Chief Executive Officer & Board Member000 0000
Martin Münchbach Ph.DSelfBoard Member000 0000
Stephen Hanson Ph.DSelfBoard Member000 0000
Arno Hartmann Ph.D Board Member Self
Brian Dovey Board Member Domain Associates
John Parrish Ph.D Co-Founder, President, Chief Executive Officer & Board Member BioVascular
Martin Münchbach Ph.D Board Member Self
Stephen Hanson Ph.D Board Member Self
Request full access to PitchBook